Valuation and consulting for financial reporting, federal, state and local tax, investment and risk management purposes.Valuation Advisory
Following the launch of a new office in Madrid in March 2014, Duff & Phelps pursues commitment to growth in independent valuation and corporate finance advisory services in the European market
Duff & Phelps’ team in Paris now comprises three managing directors under the leadership of Yann Magnan, head of the Paris office and leader for valuation services in Europe
Duff & Phelps Corporation, the premier global valuation and corporate finance advisor, today announced that Carine Tourneur joins the firm’s Paris office as a managing director in the firm’s Valuation Advisory practice.
Tourneur brings more than 20 years of experience in corporate finance and capital markets spanning Investment Banking in Brussels (Banque Indosuez which became Cera Bank and then KBC), in Financial Communication (Actus Finance and W&Cie) and, since 2001, as a partner at Deloitte Finance in France. She has advised large listed companies, banks and funds in corporate valuation (purchase price allocation, impairment test, equities valuation), intangible assets valuation (trademarks, patents, customer relationships, contracts) and the valuation of private equity portfolios as well as management packages. She has performed valuations for accounting, transaction and tax purposes in regards with M&A, internal reorganization, litigation, international arbitrage and independent expertise and fairness opinions.
Tourneur’s industry expertise in Consumer and Industrial Products, amongst others, complements the Paris team’s strong capabilities in Telecoms, Financial Services, Healthcare, Aerospace and Defense. She brings strong relationships with large French corporates, banks and private investors and expands the firm’s strong base of contacts with the most active companies listed on the CAC 40 and SBF 120.
“After the launch of a new office in Madrid, Carine Tourneur's arrival strengthens the Paris team and demonstrates our commitment to continued growth in France and Europe for our valuation and corporate finance advisory activities in accordance with our clients’ needs and market evolutions,” explains Yann Magnan, Managing Director, Head of the Paris office and leader for valuation services in Europe. "Duff & Phelps intends to pursue growth in France and Europe in the coming months, through recruitment of managing directors and directors, and through potential acquisitions, thereby enhancing our ability to advise clients on the largest and most complex valuation challenges they face in a context of a global increase in M&A."
Duff & Phelps is one of the leading valuation advisory services firms in France and Europe. The Paris office includes 15 experienced consultants, with three managing directors (Yann Magnan, Marc Melou, Carine Tourneur) and and two directors (Jérôme Caldeira and Rita Chraibi). The Paris team leverages a unique expertise combining financial and accounting skills backed by the experience of industry experts and a global platform of 30 offices throughout North America, Europe and Asia and 1000 professionals worldwide.
About Duff & Phelps
Duff & Phelps is the premier global valuation and corporate finance advisor with expertise in complex valuation, dispute consulting, M&A and restructuring. The firm’s more than 1,000 employees serve a diverse range of clients from offices in North America, Europe and Asia. For more information, visit www.duffandphelps.com.
M&A advisory, capital raising and restructuring services in the United States are provided by Duff & Phelps Securities, LLC. Member FINRA/SIPC. Pagemill Partners is a Division of Duff & Phelps Securities, LLC. M&A advisory and capital raising services in the United Kingdom and Germany are provided by Duff & Phelps Securities Ltd., which is authorized and regulated by the Financial Conduct Authority.
has sold its Power Solutions Business to
Independent financial advisor to the board of directors of Johnson Controls
Duff & Phelps advised BioNTech AG on the collaboration deal with Pfizer
June 3-5, 2019 Harrogate
March 24-27, 2019 LA